Ignite Creation Date:
2024-05-06 @ 12:27 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03767491
Status:
WITHDRAWN
Last Update Posted:
2022-08-08
First Post:
2018-12-05
Brief Title:
Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder OCD
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Study Overview
Official Title:
Smartphone Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder A Randomized Waitlist-control Trial
Status:
WITHDRAWN
Status Verified Date:
2020-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study must be registered under the sponsor instead of the site so we have created a new posting in the sponsors account
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy CBT treatment for obsessive compulsive disorder OCD The investigators hypothesize that participants receiving app-CBT will have greater improvement in Y-BOCS scores than those in the waitlist condition at treatment endpoint week 12
Detailed Description:
The primary aims of this study are to test the efficacy of a Smartphone-based CBT treatment for adults with OCD recruited nationally Eligible subjects N58 will be randomly assigned to 12 weeks of Smartphone-delivered CBT for OCD either immediately or after a 12-week long waiting period 50-50 chance The investigators hypothesize that Smartphone-delivered CBT for OCD will be feasible and acceptable to individuals with OCD and that it will lead to greater reductions in OCD symptom severity compared to the passage of time waitlist control
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
True
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None